HSP90B1 and cancer: Immunotherapy of cancer patients with autologous, tumor derived gp96 has been shown to increase the frequency of NK cells in peripheral blood, as well as the expression of their activating receptors and IFNγ following re-stimulation ex vivo16, 17.